Dynavax Technologies Q1 2024 GAAP EPS $(0.07) Misses $(0.03) Estimate, Sales $50.790M Miss $54.975M Estimate
Portfolio Pulse from Benzinga Newsdesk
Dynavax Technologies reported Q1 2024 GAAP EPS of $(0.07), missing the $(0.03) estimate, with sales of $50.790M also missing the $54.975M estimate. This represents an 8.24% increase in sales compared to the same period last year.
May 08, 2024 | 8:02 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Dynavax Technologies missed Q1 2024 earnings and sales estimates, with a GAAP EPS of $(0.07) and sales of $50.790M.
Missing both EPS and sales estimates typically leads to negative investor sentiment in the short term, potentially causing a decrease in stock price. The reported 8.24% YOY sales increase may not fully mitigate the negative impact of missing estimates.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100